Summary of findings 1. Performance of the six most evaluated first and second trimester serum test strategies with or without ultrasound.
Test strategy (with maternal age) | Studies | Women (cases) | Sensitivity (95% CI) at a 5% FPR | Test* |
First trimester PAPP‐A and second trimester total hCG, uE3 and AFP | 4 | 2474 (236) | 85 (78, 89) | P = 0.014 |
First trimester PAPP‐A and second trimester total hCG, uE3, AFP and inhibin A | 3 | 35,361 (217) | 87 (81, 91) | |
First trimester NT and second trimester total hCG and AFP | 4 | 22,793 (135) | 85 (77, 91) | |
First trimester NT and second trimester total hCG, uE3 and AFP | 4 | 13,708 (136) | 86 (78, 92) | |
First trimester NT and PAPP‐A, and second trimester total hCG, uE3, AFP and inhibin A | 3 | 39,670 (184) | 95 (90, 97) | |
First trimester NT and PAPP‐A, and second trimester free ßhCG, uE3, AFP and inhibin A | 4 | 40,348 (266) | 92 (88, 95) |
*Likelihood ratio test for the difference in accuracy between the six test strategies compared in a single meta‐analytic model
AFP = alpha‐fetoprotein; ßhCG = beta human chorionic gonadotrophin; FPR = false positive rate;hCG = human chorionic gonadotrophin; NT = nuchal translucency; PAPP‐A = pregnancy‐associated plasma protein‐A; uE3 = unconjugated oestriol
CI = confidence interval